Jianxing Medical Fund is an equity investment fund managed by CCB International, co-operated by Beijing New Aerotropolis Fund.
Jianxing Medical Fund is an equity investment fund managed by CCB International and co-operated by Beijing New Aerotropolis Fund Management Co., Ltd ("New Aerotropolis Fund"). The fund focuses on high-quality projects in the growth stage of innovative drugs, high-end medical equipment, and intelligent medical treatment. CCB Medical Fund is a series of equity investment funds set up by CCB International to develop in the medical and health industry in China, including CCB Medical Fund I, Jianxing Medical Fund and CCB Medical Growth Fund, etc.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 2, 2022
Saifu Pharmaceutical
|
Series D | ¥500M | Health Care | — |
Dec 27, 2021
Leyue Health
|
Series B | — | Commercial Insurance | — |
Jun 15, 2020
Shukun Technology
|
Series B | ¥200M | Artificial Intelligence | — |
Dec 6, 2019
Hygea Medical Technology
|
Series B | $28M | Biopharma | Yes |